Invasion and metastasis: biology and clinical potential

E C Kohn1

  • 1Medicine Branch, National Cancer Institute, Bethesda, MD 20892.

Insights

Understanding tumor metastasis, the main cause of cancer death, reveals new diagnostic and treatment strategies. Research into the metastatic cascade identifies key molecular targets for novel anti-cancer therapies.

Area of Science:

  • Oncology
  • Cancer Biology
  • Molecular Medicine

Background:

  • Tumor metastasis is the leading cause of cancer-related mortality.
  • The metastatic cascade involves complex cellular and molecular processes.
  • Understanding these processes offers opportunities for novel cancer therapies.

Purpose of the Study:

  • To review the key molecular components and processes of the metastatic cascade.
  • To highlight the clinical relevance of these components in cancer diagnosis and follow-up.
  • To discuss emerging anti-cancer drug targets based on metastatic pathways.

Main Methods:

  • Review of literature on tumor metastasis and the metastatic cascade.
  • Analysis of molecular patterns in malignant and metastatic tissues.
  • Correlation of molecular findings with clinical outcomes.
  • Identification of potential therapeutic targets and drug candidates.

Main Results:

  • Identified reproducible molecular patterns in metastatic tissues related to angiogenesis, cell adhesion, proteolysis, migration, and proliferation.
  • Established clinical correlations demonstrating the utility of these patterns in identifying and monitoring malignant and metastatic disease.
  • Highlighted several promising drug classes, including angiogenesis inhibitors, protease inhibitors, and signal transduction blockers.

Conclusions:

  • The study of the metastatic cascade provides critical insights into cancer progression.
  • Molecular patterns within the cascade are valuable for clinical applications in cancer management.
  • Emerging therapeutic strategies targeting the metastatic cascade hold significant promise for future cancer treatment.

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...